## BACKGROUND. At the current time, there is nearly universal agreement that screening for the early detection of lung carcinoma is not justified. This is based on the fact that, to the author's knowledge, no randomized population trial (RPT) to date has demonstrated a significant reduction in lun
β¦ LIBER β¦
Screening for lung cancer : Do we need randomized trials?
β Scribed by Olli S. Miettinen
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 87 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Randomized population trials and screeni
β
Gary M. Strauss
π
Article
π
2000
π
John Wiley and Sons
π
English
β 212 KB
π 2 views
Quebec randomized controlled trial on pr
β
Boer, Rob; SchrοΏ½der, Fritz H.
π
Article
π
1999
π
John Wiley and Sons
π
English
β 75 KB
π 1 views
An Estimate of the Variance of Estimator
β
Karen Kafadar; Philip C. Prorok; Paul J. Smith
π
Article
π
1998
π
John Wiley and Sons
π
English
β 225 KB
π 2 views
Variance estimators are derived for estimators of the average lead time and average benefit time due to screening in a randomized screening trial via influence functions. The influence functions demonstrate that these estimators are asymptotically equivalent to the mean difference, between the study
Survival benefit in a randomized clinica
β
E. Lindholm; H. Brevinge; E. Haglind
π
Article
π
2008
π
John Wiley and Sons
π
English
β 121 KB
π 1 views
Survival benefit in a randomized clinica
β
A. P. Corder; M. Iqbal; S. Devaraj
π
Article
π
2008
π
John Wiley and Sons
π
English
β 63 KB
Authors' reply: Survival benefit in a ra
β
E. Haglind; E. Lindholm; H. Brevinge
π
Article
π
2008
π
John Wiley and Sons
π
English
β 53 KB